Cancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern in normal tissues and aberrant expression in different types of tumors being considered promising candidates for immunotherapy. We used the alignment between EST sequences and the human genome sequence to identify novel CT genes. By examining the EST tissue composition of known CT clusters we defined parameters for the selection of 1184 EST clusters corresponding to putative CT genes. The expression pattern of 70 CT gene candidates was evaluated by RT-PCR in 21 normal tissues, 17 tumor cell lines and 160 primary tumors. We were able to identify 4 CT genes expressed in different types of tumors. The presence of antibodies against the protein encoded b...
Cancer/Testis (CT) genes, normally expressed in germ line cells but also activated in a wide range o...
FATE and TPTE genes were originally reported to be specifically expressed in the adult testis. We se...
Purpose: Among tumor antigens identified to date, cancer-testis (CT) antigens, which are coded by CT...
Cancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern in norma...
AbstractCancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern ...
The identification of cancer-specific biomolecules is of fundamental importance to the development o...
The identification of tumour antigens (TAs) represents an ongoing challenge to the development of no...
The potency of the immune response has still to be harnessed effectively to combat human cancers. Ho...
Transcripts with ESTs derived exclusively or predominantly from testis, and not from other normal ti...
Immunotherapy for cancer has been recognized as the fourth therapeutic method after surgery, radioth...
Cancer/testis antigens (CTAs) are a kind of antigens that their expression mostly is restricted in t...
Transcripts with ESTs derived exclusively or predominantly from testis, and not from other normal ti...
Cancer-testis (CT) antigens/genes show restricted expression in normal tissues but widespread expres...
Cancer-testis (CT) antigens/genes show restricted expression in normal tissues but widespread expres...
International audienceCancer-testis (CT) Ags are attractive targets for immunotherapeutic strategies...
Cancer/Testis (CT) genes, normally expressed in germ line cells but also activated in a wide range o...
FATE and TPTE genes were originally reported to be specifically expressed in the adult testis. We se...
Purpose: Among tumor antigens identified to date, cancer-testis (CT) antigens, which are coded by CT...
Cancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern in norma...
AbstractCancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern ...
The identification of cancer-specific biomolecules is of fundamental importance to the development o...
The identification of tumour antigens (TAs) represents an ongoing challenge to the development of no...
The potency of the immune response has still to be harnessed effectively to combat human cancers. Ho...
Transcripts with ESTs derived exclusively or predominantly from testis, and not from other normal ti...
Immunotherapy for cancer has been recognized as the fourth therapeutic method after surgery, radioth...
Cancer/testis antigens (CTAs) are a kind of antigens that their expression mostly is restricted in t...
Transcripts with ESTs derived exclusively or predominantly from testis, and not from other normal ti...
Cancer-testis (CT) antigens/genes show restricted expression in normal tissues but widespread expres...
Cancer-testis (CT) antigens/genes show restricted expression in normal tissues but widespread expres...
International audienceCancer-testis (CT) Ags are attractive targets for immunotherapeutic strategies...
Cancer/Testis (CT) genes, normally expressed in germ line cells but also activated in a wide range o...
FATE and TPTE genes were originally reported to be specifically expressed in the adult testis. We se...
Purpose: Among tumor antigens identified to date, cancer-testis (CT) antigens, which are coded by CT...